Matches in SemOpenAlex for { <https://semopenalex.org/work/W1997668843> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W1997668843 endingPage "1417" @default.
- W1997668843 startingPage "1415" @default.
- W1997668843 abstract "AZA has been reported to cause liver dysfunction in some recipients of solid organ transplants. To assess the safety and efficacy of cyclophosphamide in maintenance immunosuppression in the setting of AZA-induced liver dysfunction, we retrospectively reviewed the records of 320 surviving cardiac transplant recipients in Utah. Cyclophosphamide was substituted for AZA in 29 patients due to elevated liver enzymes. Patients were switched to cyclophosphamide 689±104 days after transplantation; total follow-up after initiation of cyclophosphamide was 540±56 days. The dose of cyclophosphamide after 2 and 6 months of cyclophosphamide therapy was 62±6 mg/day (0.8±0.1 mg/kg/day) and 48±5 mg/day (0.6±0.1 mg/kg/day), respectively, compared with 233±20 mg/day (2.9±0.2 mg/kg/day) of AZA. The substitution of cyclophosphamide for AZA was associated with a significant improvement in liver function tests. Liver enzymes decreased by up to 49% (P=0.027), while serum bilirubin decreased by 58% (P<0.001). Rejection frequency did not increase; neither corticosteroid nor CsA dosage was altered significantly after the substitution of cyclophosphamide. Significant bone marrow suppression was not observed; specifically, no significant change in white blood cell count or hematocrit occurred. Complications of treatment with cyclophosphamide were few; only 1 patient discontinued cyclophosphamide because of alopecia. We conclude that cyclophosphamide appears to be safe in maintenance immunosuppression, permitting the discontinuation of AZA in patients with AZA-induced hepatic dysfunction without necessitating the augmentation of either corticosteroids or CsA." @default.
- W1997668843 created "2016-06-24" @default.
- W1997668843 creator A5003541624 @default.
- W1997668843 creator A5019715623 @default.
- W1997668843 creator A5025101815 @default.
- W1997668843 creator A5025153573 @default.
- W1997668843 creator A5038927942 @default.
- W1997668843 creator A5042834490 @default.
- W1997668843 creator A5067239184 @default.
- W1997668843 date "1993-12-01" @default.
- W1997668843 modified "2023-10-18" @default.
- W1997668843 title "CYCLOPHOSPHAMIDE AS AN ALTERNATIVE TO AZATHIOPRINE IN CARDIAC TRANSPLANT RECIPIENTS WITH SUSPECTED AZATHIOPRINE-INDUCED HEPATOTOXICITY" @default.
- W1997668843 doi "https://doi.org/10.1097/00007890-199312000-00027" @default.
- W1997668843 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8279012" @default.
- W1997668843 hasPublicationYear "1993" @default.
- W1997668843 type Work @default.
- W1997668843 sameAs 1997668843 @default.
- W1997668843 citedByCount "16" @default.
- W1997668843 countsByYear W19976688432013 @default.
- W1997668843 countsByYear W19976688432017 @default.
- W1997668843 countsByYear W19976688432022 @default.
- W1997668843 crossrefType "journal-article" @default.
- W1997668843 hasAuthorship W1997668843A5003541624 @default.
- W1997668843 hasAuthorship W1997668843A5019715623 @default.
- W1997668843 hasAuthorship W1997668843A5025101815 @default.
- W1997668843 hasAuthorship W1997668843A5025153573 @default.
- W1997668843 hasAuthorship W1997668843A5038927942 @default.
- W1997668843 hasAuthorship W1997668843A5042834490 @default.
- W1997668843 hasAuthorship W1997668843A5067239184 @default.
- W1997668843 hasConcept C126322002 @default.
- W1997668843 hasConcept C126894567 @default.
- W1997668843 hasConcept C141071460 @default.
- W1997668843 hasConcept C2776581026 @default.
- W1997668843 hasConcept C2776694085 @default.
- W1997668843 hasConcept C2776755627 @default.
- W1997668843 hasConcept C2776760755 @default.
- W1997668843 hasConcept C2778670039 @default.
- W1997668843 hasConcept C2778715236 @default.
- W1997668843 hasConcept C2779134260 @default.
- W1997668843 hasConcept C2780252810 @default.
- W1997668843 hasConcept C2780873365 @default.
- W1997668843 hasConcept C2992208098 @default.
- W1997668843 hasConcept C71924100 @default.
- W1997668843 hasConcept C90924648 @default.
- W1997668843 hasConceptScore W1997668843C126322002 @default.
- W1997668843 hasConceptScore W1997668843C126894567 @default.
- W1997668843 hasConceptScore W1997668843C141071460 @default.
- W1997668843 hasConceptScore W1997668843C2776581026 @default.
- W1997668843 hasConceptScore W1997668843C2776694085 @default.
- W1997668843 hasConceptScore W1997668843C2776755627 @default.
- W1997668843 hasConceptScore W1997668843C2776760755 @default.
- W1997668843 hasConceptScore W1997668843C2778670039 @default.
- W1997668843 hasConceptScore W1997668843C2778715236 @default.
- W1997668843 hasConceptScore W1997668843C2779134260 @default.
- W1997668843 hasConceptScore W1997668843C2780252810 @default.
- W1997668843 hasConceptScore W1997668843C2780873365 @default.
- W1997668843 hasConceptScore W1997668843C2992208098 @default.
- W1997668843 hasConceptScore W1997668843C71924100 @default.
- W1997668843 hasConceptScore W1997668843C90924648 @default.
- W1997668843 hasIssue "6" @default.
- W1997668843 hasLocation W19976688431 @default.
- W1997668843 hasLocation W19976688432 @default.
- W1997668843 hasOpenAccess W1997668843 @default.
- W1997668843 hasPrimaryLocation W19976688431 @default.
- W1997668843 hasRelatedWork W1573219848 @default.
- W1997668843 hasRelatedWork W1997668843 @default.
- W1997668843 hasRelatedWork W2010520934 @default.
- W1997668843 hasRelatedWork W2074837540 @default.
- W1997668843 hasRelatedWork W2079652868 @default.
- W1997668843 hasRelatedWork W2192451422 @default.
- W1997668843 hasRelatedWork W2351585609 @default.
- W1997668843 hasRelatedWork W2392867889 @default.
- W1997668843 hasRelatedWork W4249342726 @default.
- W1997668843 hasRelatedWork W5047642 @default.
- W1997668843 hasVolume "56" @default.
- W1997668843 isParatext "false" @default.
- W1997668843 isRetracted "false" @default.
- W1997668843 magId "1997668843" @default.
- W1997668843 workType "article" @default.